NW16
NW16 is an orally bioavailable STAT3 inhibitor (Kd = 11.0 μM) that exhibits potent anti-proliferative activity in vitro against HCT116, A549, and B16 cancer cells. It induces S-phase arrest, apoptosis, and ROS production while suppressing the PI3K/AKT pathway, and has demonstrated in vivo antitumor efficacy in mouse models.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation, Signal Transduction, Stem Cell & Developmental Biology
Molecular Formula
C18H12N2O5
Molecular Weight
336.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
DXC58558-01 50 mg
2- (1H-Imidazol-2-yl) pyridine-4-carboxylic acid dihydrochloride
Sign In for Pricing
View Details DXC58558-02 0.5 g
2- (1H-Imidazol-2-yl) pyridine-4-carboxylic acid dihydrochloride
Sign In for Pricing
View Details